Pancreatic cancer: Current factors and options to determine future research

Hepato-Gastroenterology

Volumn 47, Issue 34, 2000, Pages 1170-1175

  Lygidakis, N J ^a  

^a NONE   (Greece)

Author keywords

Clinical trials; Diagnostic factors; Laparoscopy; Neo adjuvant locoregional immunochemotherapy; Pancreatic cancer; Resection; Treatment modalities

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN; MITOXANTRONE;

CANCER SCREENING; CANCER SURGERY; CHEMOTHERAPY; DIAGNOSTIC ACCURACY; HUMAN; LAPAROSCOPY; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL RATE; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS; HUMAN; IMMUNOTHERAPY; LAPAROSCOPY; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS;

EID: 0033803699     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Clinicopathological features in misdiagnosed pancreatic carcinoma
2. Early diagnosis of pancreatic cancer
3. Significance of K-ras codon 12 point mutation in pancreatic juice in the diagnosis of carcinoma of the pancreas
4. Diagnosis of pan can by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy
5. Increased blood proinsulin and decreased c-peptide levels in patients with pan can
6. Minute carcinoma of the pancreas - Collective review of Japanese case reports
7. Peritoneal washings cytology combined with immunocytochemical staining in pancreatic cancer
8. Diagnosis of mucin-producing tumor of the pancreas by balloon-catheter endoscopic retrograde pancreatography-compression study
9. Mucin-producing tumors of the pancreas - Why they deserve more attention
10. Advances in pancreatic biliary imaging
11. Pancreatic cancer staging: Go with the CT alone?
12. Is age a risk factor for major pancreatic surgery? An analysis of 300 resections
13. Factors affecting morbidity, mortality and survival after pancreaticoduodenectomy for carcinoma of the ampulla of vater
14. Clinicopathological evaluation of long-term survivors treated for cancer of the head of pancreas
15. The role of MIB-1 index in the prognosis of resectable pancreatic head cancer
16. Possibility of slow-growing variants in pancreatic adenocarcinoma
17. Sialylated MUC1 mucin expression in normal pancreas, bening pancreatic lesions and pancreatic ductal adenocarcinoma
18. Economic evaluations of gastric and pancreatic cancer
19. Health-related quality of life evaluations of gsastric and pancreatic cancer
20. Surgical treatment of pancreatic tumors invading the spleno-mesenteric-portal vessels. An Italian multi-center survey
21. Extensive resection in pancreatic cancer: Review of the literature and personal experience
22. Clinical and biological features of t1 ductal adenocarcinoma of the pancreas
23. Pancreatic carcinoma: Reappraisal of surgical experiences in one Japanese university hospital
24. Surgery for nucin-producing pancreatic tumor
25. Characteristics and treatment of mucin-producing tumor of the pancreas
26. Segmental pancreatectomy for mucin-producing pancreatic tumors
27. Management of the pancreatic metastases from renal cell carcinoma: Report of four resected cases
28. Operative indications for cystic lesions of the pancreas with malignant potential - Our experience
29. Laparoscopic pancreatic surgery: Indications, techniques and preliminary results
30. Advanced small cell pancreatic cancer: Relevance of laparoscopic staging
31. Surgical palliation in pancreatic head carcinoma and gastric cancer: The role of laparoscopy
32. Pancreatic resection for pancreatic carcinoma combined with neo and adjuvant locoregional targeting immunochemotherapy - A prospective randomized study
33. Intrasplenic immunostimulation in malignancies. Fact or fiction? Present and future
34. A prospective randomized study using adjuvant locoregional chemoimmunotherapy in combination with surgery for pancreatic carcinoma
35. Regional versus systemic chemotherapy for advanced pancreatic cancer: A randomized study
36. Prospective randomized trial of 5-fluoracil, doxorubicin and mitomycin C for non-resectable pancreatic and biliary carcinoma - Multi-center trial
37. 5-Fluorouracil continuous infusion combined with cispatin for advanced pancreatic cancer: A Japanese cooperative study
38. Consecutive re-explorations for final resection of initially unresectable pancreatic head carcinoma
39. Locoregional chemotherapy in pancreatic cancer
40. The evidence for multimodality treatment of pancreatic cancer
41. Regional vascular resection for pancreatic head carcinoma